Literature DB >> 23608859

Severe necrotic oesophageal and gastric ulceration associated with dabigatran.

Saurabh Singh1, Louis Savage, Martin Klein, Cherian Thomas.   

Abstract

A 69-year-old Caucasian man, who had been discharged 2 days previously, 5 days post-elective right total hip replacement, was re-admitted with a 16 h history of coffee-ground vomiting and epigastric pain. He had been discharged with 220 mg dabigatran, a novel oral anticoagulant. The coffee-ground vomiting started within minutes of taking the first dose. Haemodynamic compromise, agitation, decreasing conscious level and aspiration pneumonia necessitated intubation, ventilation and inotropic support in the intensive care unit. A CT on admission showed extensive intramural air seen within the lower oesophagus and a dilated stomach, duodenum and jejunum. Endoscopy of the upper gastrointestinal tract showed extensive ulceration, sloughing and multiple areas of necrosis in the distal oesophagus and stomach. The patient made a fully recovery with supportive management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23608859      PMCID: PMC3645015          DOI: 10.1136/bcr-2013-009139

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Exfoliative esophagitis and esophageal ulcer induced by dabigatran.

Authors:  M Okada; K Okada
Journal:  Endoscopy       Date:  2012-03-06       Impact factor: 10.093

2.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 3.  Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.

Authors:  Antonio Gómez-Outes; Ana Isabel Terleira-Fernández; M Luisa Suárez-Gea; Emilio Vargas-Castrillón
Journal:  BMJ       Date:  2012-06-14
  3 in total
  6 in total

1.  Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

2.  Pradaxa-induced esophageal ulcer.

Authors:  Michele Wood; Paul Shaw
Journal:  BMJ Case Rep       Date:  2015-10-09

Review 3.  Dabigatran must be used carefully: literature review and recommendations for management of adverse events.

Authors:  Shan Lin; Yan Wang; Lei Zhang; Wei Guan
Journal:  Drug Des Devel Ther       Date:  2019-05-06       Impact factor: 4.162

4.  Acute Lower Gastrointestinal Bleeding in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice: Characteristics and Clinical Outcome.

Authors:  Georgia Diamantopoulou; Christos Konstantakis; George Skroubis; George Theocharis; Vasilios Theopistos; Christos Triantos; Konstantinos Thomopoulos
Journal:  Gastroenterology Res       Date:  2019-02-26

5.  The Risks of Exfoliative Esophagitis in Patients with Atrial Fibrillation: A retrospective observational study.

Authors:  Hiroki Tajima; Toshiaki Narasaka; Daisuke Akutsu; Hideo Suzuki; Hirofumi Matsui; Kazushi Maruo; Hiro Yamasaki; Yuji Mizokami
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

6.  Dabigatran-induced esophagitis: A case report.

Authors:  Yi Zhou; Yancheng Dai; Lei Lu; Zhiquan Fu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.